Clinical trial
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
NCT03614260 is registered in ClinicalTrials.gov with ReCor Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
- Lead sponsor
- ReCor Medical, Inc.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- December 14, 2018
- Completion date
- July 31, 2029
- Enrollment
- 224 (actual)
- Sites
- 47
Conditions
As the registry lists them; a condition with its own page is linked.